Ventures Llc Amgen serves as Executive at Epizyme, Inc., where they oversee executive responsibilities. Since joining the company, Ventures Llc Amgen has executed 6 insider transactions totaling $2.2M, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 17, 2013 involved exercising options for 448,767 shares valued at $0.
Ventures Llc Amgen currently holds 448,767 shares of Epizyme, Inc. (EPZM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ventures Llc Amgen has been a net buyer of EPZM stock. They have purchased $2.2M and sold $0 worth of shares.
Ventures Llc Amgen's most recent insider trade was on Dec 17, 2013, when they sold 448,767 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $6.40 |
| Discretionary |
| Dec 17, 2013 | TLOG | $1.9M | Purchase | 272,142 | $7.00 | Discretionary |
| Dec 17, 2013 | TLOG | $0 | Conversion | 268,116 | $N/A | Discretionary |
| Jun 5, 2013 | EPZM | $250.0K | Purchase | 16,666 | $15.00 | Discretionary |
| Jun 5, 2013 | EPZM | $0 | Conversion | 317,460 | $N/A | Discretionary |